Chem4Pharma


Logo

Company Logo - Chem4Pharma


Contact Data

Phone number: +351 231 249 283
Fax number:
Address line 1: Edifício IPN Incubadora
Address line 2: Rua Pedro Nunes
City: Coimbra
State/Province/Region:
Zip/Postal code: 3030-199
Country: Portugal
Web page: https://www.chem4pharma.com/


Notes

CHEM4PHARMA is a science-based company specialized in Research and Drug Development that offers high quality and innovative natural product-like semisynthetic libraries for HTS and other assays. CHEM4PHARMA provides several customized services for R&D, including computer-assisted drug design, custom synthesis, process optimization, and scientific advice. The company aims to provide high-quality synthesis of drug-like molecules and molecular modeling services on the basis of contract research.



Compounds

First Previous Previous 1 2 3 4 5 6 Next Next Last

# Catalog Number IUPAC
1. C4PB282 (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-icosahydro-1H-cyclopenta[a]chrysene-3a-carboxylic acid
2. C4PB283 (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-(hydroxymethyl)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-icosahydro-1H-cyclopenta[a]chrysen-9-ol
3. C4PB1 [(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-icosahydro-1H-cyclopenta[a]chrysen-3a-yl]methyl 1H-imidazole-1-carboxylate
4. C4PB2 (1R,3aS,5aR,5bR,7aR,11aR,11bR,13aR,13bR)-3a-(1H-imidazole-1-carbonyl)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-icosahydro-1H-cyclopenta[a]chrysen-9-one
5. C4PB3 (1R,3aS,5aR,5bR,7aR,11aR,11bR,13aR,13bR)-3a-(1H-imidazole-1-carbonyl)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-1H,2H,3H,3aH,4H,5H,5aH,5bH,6H,7H,7aH,8H,9H,11aH,11bH,12H,13H,13aH,13bH-cyclopenta[a]chrysen-9-one
6. C4PB4 (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-(hydroxymethyl)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-icosahydro-1H-cyclopenta[a]chrysen-9-yl 1H-imidazole-1-carboxylate
7. C4PB5 (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-[(1H-imidazole-1-carbonyloxy)methyl]-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-icosahydro-1H-cyclopenta[a]chrysen-9-yl 1H-imidazole-1-carboxylate
8. C4PB6 [(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bS)-9-hydroxy-1-(3-methoxyprop-1-en-2-yl)-5a,5b,8,8,11a-pentamethyl-icosahydro-1H-cyclopenta[a]chrysen-3a-yl]methyl 1H-imidazole-1-carboxylate
9. C4PB7 [(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bS)-9-(1H-imidazole-1-carbonyloxy)-1-(3-methoxyprop-1-en-2-yl)-5a,5b,8,8,11a-pentamethyl-icosahydro-1H-cyclopenta[a]chrysen-3a-yl]methyl 1H-imidazole-1-carboxylate
10. C4PB8 [(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-[(2R)-1-oxopropan-2-yl]-icosahydro-1H-cyclopenta[a]chrysen-3a-yl]methyl 1H-imidazole-1-carboxylate
11. C4PB9 [(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-(1H-imidazole-1-carbonyloxy)-5a,5b,8,8,11a-pentamethyl-1-[(2R)-1-oxopropan-2-yl]-icosahydro-1H-cyclopenta[a]chrysen-3a-yl]methyl 1H-imidazole-1-carboxylate
12. C4PB10 [(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-(acetyloxy)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-icosahydro-1H-cyclopenta[a]chrysen-3a-yl]methyl 1H-imidazole-1-carboxylate
13. C4PB12 [(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-icosahydro-1H-cyclopenta[a]chrysen-3a-yl]methyl 1H-1,2,4-triazole-1-carboxylate
14. C4PB13 [(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-9-(2-methyl-1H-imidazole-1-carbonyloxy)-1-(prop-1-en-2-yl)-icosahydro-1H-cyclopenta[a]chrysen-3a-yl]methyl 2-methyl-1H-imidazole-1-carboxylate
15. C4PB15 (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-(hydroxymethyl)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-icosahydro-1H-cyclopenta[a]chrysen-9-yl 1H-1,2,4-triazole-1-carboxylate
16. C4PB16 (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-[(acetyloxy)methyl]-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-icosahydro-1H-cyclopenta[a]chrysen-9-yl 2-methyl-1H-imidazole-1-carboxylate
17. C4PB17 (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-[(acetyloxy)methyl]-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-icosahydro-1H-cyclopenta[a]chrysen-9-yl 1H-1,2,4-triazole-1-carboxylate
18. C4PB18 [(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-(acetyloxy)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-icosahydro-1H-cyclopenta[a]chrysen-3a-yl]methyl 2-methyl-1H-imidazole-1-carboxylate
19. C4PB19 [(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-(acetyloxy)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-icosahydro-1H-cyclopenta[a]chrysen-3a-yl]methyl 1H-1,2,4-triazole-1-carboxylate
20. C4PB20 [(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-[(2R)-1-oxopropan-2-yl]-icosahydro-1H-cyclopenta[a]chrysen-3a-yl]methyl 2-methyl-1H-imidazole-1-carboxylate
21. C4PB21 [(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bS)-9-hydroxy-1-(3-methoxyprop-1-en-2-yl)-5a,5b,8,8,11a-pentamethyl-icosahydro-1H-cyclopenta[a]chrysen-3a-yl]methyl 2-methyl-1H-imidazole-1-carboxylate
22. C4PB23 [(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bS)-1-(3-methoxyprop-1-en-2-yl)-5a,5b,8,8,11a-pentamethyl-9-(2-methyl-1H-imidazole-1-carbonyloxy)-icosahydro-1H-cyclopenta[a]chrysen-3a-yl]methyl 2-methyl-1H-imidazole-1-carboxylate
23. C4PB25 (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-9-(2-methyl-1H-imidazole-1-carbonyloxy)-1-(prop-1-en-2-yl)-icosahydro-1H-cyclopenta[a]chrysene-3a-carboxylic acid
24. C4PB27 (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-3a-(1H-1,2,4-triazole-1-carbonyl)-icosahydro-1H-cyclopenta[a]chrysen-9-yl 1H-1,2,4-triazole-1-carboxylate
25. C4PB29 (1R,3aS,5aR,5bR,7aR,11aR,11bR,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-3a-(2-methyl-1H-imidazole-1-carbonyl)-1-(prop-1-en-2-yl)-icosahydro-1H-cyclopenta[a]chrysen-9-one
26. C4PB30 (1R,3aS,5aR,5bR,7aR,11aR,11bR,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-3a-(2-methyl-1H-imidazole-1-carbonyl)-1-(prop-1-en-2-yl)-1H,2H,3H,3aH,4H,5H,5aH,5bH,6H,7H,7aH,8H,9H,11aH,11bH,12H,13H,13aH,13bH-cyclopenta[a]chrysen-9-one
27. C4PB31 (1R,3aS,5aR,5bR,7aR,11aR,11bR,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-10-(2-methyl-1H-imidazole-1-carbonyloxy)-9-oxo-1-(prop-1-en-2-yl)-1H,2H,3H,3aH,4H,5H,5aH,5bH,6H,7H,7aH,8H,9H,11aH,11bH,12H,13H,13aH,13bH-cyclopenta[a]chrysene-3a-carboxylic acid
28. C4PB32 (1R,3aS,5aR,5bR,7aR,11aR,11bR,13aR,13bR)-3a-(1H-imidazole-1-carbonyl)-5a,5b,8,8,11a-pentamethyl-9-oxo-1-(prop-1-en-2-yl)-1H,2H,3H,3aH,4H,5H,5aH,5bH,6H,7H,7aH,8H,9H,11aH,11bH,12H,13H,13aH,13bH-cyclopenta[a]chrysen-10-yl 1H-imidazole-1-carboxylate
29. C4PB33 (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-[(acetyloxy)methyl]-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-icosahydro-1H-cyclopenta[a]chrysen-9-yl 1H-imidazole-1-carboxylate
30. C4PB34 (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-(methoxycarbonyl)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-icosahydro-1H-cyclopenta[a]chrysen-9-yl 1H-imidazole-1-carboxylate
31. C4PB35 (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-(1H-imidazole-1-carbonyloxy)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-icosahydro-1H-cyclopenta[a]chrysene-3a-carboxylic acid
32. C4PB37 (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-(1H-imidazole-1-carbonyl)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-icosahydro-1H-cyclopenta[a]chrysen-9-yl 1H-imidazole-1-carboxylate
33. C4PB39 (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-(hydroxymethyl)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-icosahydro-1H-cyclopenta[a]chrysen-9-yl acetate
34. C4PB40 [(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-(acetyloxy)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-icosahydro-1H-cyclopenta[a]chrysen-3a-yl]methyl acetate
35. C4PB41 [(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-icosahydro-1H-cyclopenta[a]chrysen-3a-yl]methyl acetate
36. C4PB42 (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-[(methanesulfonyloxy)methyl]-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-icosahydro-1H-cyclopenta[a]chrysen-9-yl acetate
37. C4PB44 (1R,3aS,5aR,5bR,7aR,11aR,11bR,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-9-oxo-1-(prop-1-en-2-yl)-icosahydro-1H-cyclopenta[a]chrysene-3a-carboxylic acid
38. C4PB45 (1R,3aS,5aR,5bR,7aR,11aR,11bR,13aR,13bR)-10-hydroxy-5a,5b,8,8,11a-pentamethyl-9-oxo-1-(prop-1-en-2-yl)-1H,2H,3H,3aH,4H,5H,5aH,5bH,6H,7H,7aH,8H,9H,11aH,11bH,12H,13H,13aH,13bH-cyclopenta[a]chrysene-3a-carboxylic acid
39. C4PB46 [(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bS)-9-(acetyloxy)-1-(3-bromoprop-1-en-2-yl)-5a,5b,8,8,11a-pentamethyl-icosahydro-1H-cyclopenta[a]chrysen-3a-yl]methyl acetate
40. C4PB47 bis((1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bS)-9-hydroxy-3a-(hydroxymethyl)-5a,5b,8,8,11a-pentamethyl-icosahydro-1H-cyclopenta[a]chrysene-1-carbaldehyde)
41. C4PB48 (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bS)-3a-(hydroxymethyl)-1-(3-methoxyprop-1-en-2-yl)-5a,5b,8,8,11a-pentamethyl-icosahydro-1H-cyclopenta[a]chrysen-9-ol
42. C4PB49 (2R)-2-[(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-3a-(hydroxymethyl)-5a,5b,8,8,11a-pentamethyl-icosahydro-1H-cyclopenta[a]chrysen-1-yl]propanal
43. C4PO284 (4aS,6aS,6bR,8aR,10S,12aR,12bR,14bS)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid
44. C4PO156 (4aS,6aS,6bR,8aR,12aR,12bR,14bS)-2,2,6a,6b,9,9,12a-heptamethyl-10-oxo-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carbonyl fluoride
45. C4PO157 (3S,4aR,6aR,6bS,8aS,12aS,14aR,14bR)-8a-(carbonofluoridoyl)-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yl acetate
46. C4PO158 (4aS,6aS,6bR,8aR,12aR,12bR,14bS)-2,2,6a,6b,9,9,12a-heptamethyl-10-oxo-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid
47. C4PO159 (4aS,6aS,6bR,8aR,10E,12aR,12bR,14bS)-10-(hydroxyimino)-2,2,6a,6b,9,9,12a-heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid
48. C4PO160 (4aS,6aS,6bR,8aR,10S,12aR,12bR,14bS)-10-(acetyloxy)-2,2,6a,6b,9,9,12a-heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid
49. C4PO161 methyl (4aS,6aS,6bR,8aR,10S,12aR,12bR,14bS)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylate
50. C4PO162 (1S,4S,5R,8R,10S,13R,14R,16S,17S,18R)-10,16-dihydroxy-4,5,9,9,13,20,20-heptamethyl-24-oxahexacyclo[15.5.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-23-one

First Previous Previous 1 2 3 4 5 6 Next Next Last

 
2019 MolPort, v3.16, release date 11-09-2019 16:00 (+0200). All rights reserved.
This website or its third-party tools use cookies, which are necessary to its functioning and require to achieve the purposes illustrated in the Cookie Policy. If you want to know more or withdraw your consent to all or some of the cookies, please refer to the Cookie Policy. By clicking on Agree and closing this banner, scrolling this page, clicking a link or continuing to browse otherwise, you agree to the use of cookies.